Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Your treatment is supervised by licensed medical providers who personalize your protocol based on your unique health needs
The new drug, CagriSema, led patients to lose 22.7% of their body weight on average, below the company's reported goal of 25%, per Bloomberg
it inhibits bacterial growth, which is what allows a multi-dose vial to be punctured weekly over several weeks
In the quest for more effective treatments for diabetes, researchers have developed a groundbreaking solution that could revolutionize the way this chronic condition is managed
J.GrandtD.GoebellH
Dec 21: The FDA on Thursday signed off on the first and only self-administered treatment for polyneuropathy in hereditary transthyretin-mediated amyloidosis (hATTR-PN): AstraZeneca and Ionis eplontersen, now to be known as Wainua
US$ 23.71
US$ 21.14
US$ 29.33
US$ 24.74
US$ 29.27
US$ 28.80
US$ 22.22
US$ 21.29
